OBJECTIVE: To assess the impact of ultrasonography (US) on local corticosteroid (CS) injections of painful ankle, hindfoot, and midfoot in chronic inflammatory diseases. METHODS:Consecutive patients with chronic rheumatic diseases admitted to the hospital for local CS injections of painful ankle, hindfoot, or midfoot were enrolled in this study. Clinical and radiographic evaluation was performed by the physician in charge of CS injections, and US examination was performed by an independent examiner blinded to the clinical and radiologic findings. According to a randomized weekly-periods design, the physician planned CS injections either aware (G1 group) or unaware (G2 group) of US results. In the latter case, he was nonetheless informed of US results after he had performed the injections. Impact of this information on the treatment planning was assessed in all cases. Prognostic impact of US was also evaluated by comparing the change in global assessment of efficacy of CS injections, in activity of the disease, and in the Western Ontario and McMaster Universities (WOMAC) subscales after 1 and 3 months, between G1 and G2 groups. RESULTS: The knowledge of US findings led the physician to change his decision of local CS injections in 56 (82%) of 68 patients studied. Among 1,131 assessed sites, by clinical, radiographic, and US evaluation, injection was cancelled in 37 (15%) of 242 proposed sites, whereas it was decided in 74 (8%) additional sites. After 1 month, there was an improvement in G1 as compared with G2 groups. The mean +/- SD change in WOMAC physical function subscale was 15.6 +/- 17.5 in G1 versus 8 +/- 13 in G2 (P = 0.0305). After 3 months, only the global assessment of efficacy of CS injections was statistically greater in G1 than in G2 group (P = 0.0170). CONCLUSION: US frequently led the physician to change his diagnosis of inflammatory lesions in painful foot, and consequently his planning of CS injections. Moreover, US could improve the response to local treatment.
RCT Entities:
OBJECTIVE: To assess the impact of ultrasonography (US) on local corticosteroid (CS) injections of painful ankle, hindfoot, and midfoot in chronic inflammatory diseases. METHODS: Consecutive patients with chronic rheumatic diseases admitted to the hospital for local CS injections of painful ankle, hindfoot, or midfoot were enrolled in this study. Clinical and radiographic evaluation was performed by the physician in charge of CS injections, and US examination was performed by an independent examiner blinded to the clinical and radiologic findings. According to a randomized weekly-periods design, the physician planned CS injections either aware (G1 group) or unaware (G2 group) of US results. In the latter case, he was nonetheless informed of US results after he had performed the injections. Impact of this information on the treatment planning was assessed in all cases. Prognostic impact of US was also evaluated by comparing the change in global assessment of efficacy of CS injections, in activity of the disease, and in the Western Ontario and McMaster Universities (WOMAC) subscales after 1 and 3 months, between G1 and G2 groups. RESULTS: The knowledge of US findings led the physician to change his decision of local CS injections in 56 (82%) of 68 patients studied. Among 1,131 assessed sites, by clinical, radiographic, and US evaluation, injection was cancelled in 37 (15%) of 242 proposed sites, whereas it was decided in 74 (8%) additional sites. After 1 month, there was an improvement in G1 as compared with G2 groups. The mean +/- SD change in WOMAC physical function subscale was 15.6 +/- 17.5 in G1 versus 8 +/- 13 in G2 (P = 0.0305). After 3 months, only the global assessment of efficacy of CS injections was statistically greater in G1 than in G2 group (P = 0.0170). CONCLUSION: US frequently led the physician to change his diagnosis of inflammatory lesions in painful foot, and consequently his planning of CS injections. Moreover, US could improve the response to local treatment.
Authors: Cristina Hernández-Díaz; G Sánchez-Bringas; L Ventura-Ríos; M Robles-San Román; E Filippucci Journal: Clin Rheumatol Date: 2019-04-02 Impact factor: 2.980
Authors: Gordon J Hendry; Deborah E Turner; John McColl; Paula K Lorgelly; Roger D Sturrock; Gordon F Watt; Michael Browne; Janet Gardner-Medwin; Lorraine Friel; Jim Woodburn Journal: J Foot Ankle Res Date: 2009-06-30 Impact factor: 2.303
Authors: Cody M Young; William E Shiels; Brian D Coley; Mark J Hogan; James W Murakami; Karla Jones; Gloria C Higgins; Robert M Rennebohm Journal: Pediatr Radiol Date: 2012-09-02
Authors: Louise Laurell; Michel Court-Payen; Susan Nielsen; Marek Zak; Mikael Boesen; Anders Fasth Journal: Pediatr Rheumatol Online J Date: 2011-01-29 Impact factor: 3.054
Authors: Peter Mandl; Asta Baranauskaite; Nemanja Damjanov; Maja Hojnik; Reka Kurucz; Orsolya Nagy; Petr Nemec; Dora Niedermayer; Porin Perić; Tzvetanka Petranova; Andres Pille; Simona Rednic; Violeta Vlad; Martin Zlnay; Peter V Balint Journal: Rheumatol Int Date: 2016-02-29 Impact factor: 2.631
Authors: Gordon J Hendry; Kathryn A Gibson; Kevin Pile; Luke Taylor; Verona du Toit; Joshua Burns; Keith Rome Journal: J Foot Ankle Res Date: 2013-08-26 Impact factor: 2.303